Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Wave Life Sciences (WVE) Non-Current Receivables (2018 - 2020)

Wave Life Sciences (WVE) has disclosed Non-Current Receivables for 3 consecutive years, with $30.0 million as the latest value for Q1 2020.

  • For Q1 2020, Non-Current Receivables fell 40.0% year-over-year to $30.0 million; the TTM value through Mar 2020 reached $30.0 million, down 40.0%, while the annual FY2019 figure was $30.0 million, 40.0% down from the prior year.
  • Non-Current Receivables hit $30.0 million in Q1 2020 for Wave Life Sciences, roughly flat from $30.0 million in the prior quarter.
  • Across five years, Non-Current Receivables topped out at $50.0 million in Q2 2018 and bottomed at $30.0 million in Q2 2019.
  • Average Non-Current Receivables over 3 years is $40.0 million, with a median of $40.0 million recorded in 2018.
  • On a YoY basis, Non-Current Receivables climbed as much as 40.0% in 2019 and fell as far as 40.0% in 2019.
  • Wave Life Sciences' Non-Current Receivables stood at $50.0 million in 2018, then tumbled by 40.0% to $30.0 million in 2019, then changed by 0.0% to $30.0 million in 2020.
  • According to Business Quant data, Non-Current Receivables over the past three periods came in at $30.0 million, $30.0 million, and $30.0 million for Q1 2020, Q4 2019, and Q3 2019 respectively.